Jonathan KaskeyUnclaimed
Host of Pharma Sessions.
1 Feed-stated
Counts Verified and Feed-stated credits: what a show's own feed states, or a confirmation backs. See the record
- Host
Claim this profile Add a creditIs this you? Claiming needs a free account. You sign in or join, then come straight back here.
This profile is unclaimed. PodSubs built it from public show feeds and credits. The person it is about has not reviewed it yet.
PodCred record
PodCred is the verified record of where Jonathan has worked and appeared. These credits come from the shows' own feeds and wait for people who were there to confirm them.
Worked with Jonathan on a show? This is where you give them credit.
Shows they work on now
1 show
Is an appearance missing?
People get invited back because someone remembered they were great. If you heard this person on a show and it is not listed here, add it. Your memory might be the reason they get their next invitation.
No account needed. Anyone can give a credit.
Experience, education, skills, and recommendations start empty. They fill in when Jonathan claims this profile.
Recommendations
No recommendations for Jonathan yet.
Recommendations open once Jonathan claims the profile.
Posts
No posts yet. Posts Jonathan shares on PodSubs, and what Jonathan publishes on Substack, YouTube and elsewhere, will show here.
Recent episodes
From the shows they work on now
Built to Move: Candel Therapeutics' Agile Path from Trial Results to Launch Readiness
Dr. Paul Peter Tak, President and CEO of Candel Therapeutics, sits down with Jonathan to discuss the company's sprint from positive Phase III results to commercial launch. They explore how Candel is redefining the...
Data, AI, and the Future of Field Training with Annel Duckels from BMS
In this episode, Jonathan sits down with Annel Duckels, who leads worldwide commercialization learning at Bristol Myers Squibb, to talk about modernizing pharma training through data and AI. Annel's unconventional path...
Hallway Interviews with Pharma Learning Leaders
Pharma Sessions - ACTO Client Summit: Hallway Interviews At ACTO's 2026 client summit in Boston, we pulled some incredible minds out of the hallway for quick, candid conversations about where field excellence, AI, and...
Blockchain + AI: The Future of Healthcare Data
What happens when you put blockchain underneath AI in healthcare? According to Archita Samant, Head of Data Strategy & Analytics for Global Vaccines at Merck - you finally solve the interoperability problem that's been...
The Question Behind the Question - Field Training with Jennifer Muszik
What separates a good pharma sales rep from a great one? According to Jennifer Muszik, it's the ability to understand the question behind the question - the real need behind what a customer is asking. In this episode,...
Why the Small Details Reveal Everything About Your CDMO Partner with Frank Sorce
In this episode of Pharma Sessions, host Jonathan Kaskey is joined by Frank Sorce, Chief Commercial Officer at UPM Pharmaceuticals, to share insights into the critical decisions involved in selecting contract...
Why Medical Knowledge Isn’t Reaching Patients with Dr. Simon Chowdhury
In this episode of Pharma Sessions, host Jonathan Kaskey is joined by Dr. Simon Chowdhury, a Consultant Medical Oncologist based at Guy's and St Thomas' NHS Foundation Trust, to talk about Open Medicine, a platform...
Timothy Smith on AI, Data, and Drug Discovery at Takeda
In this episode of Pharma Sessions, host Jonathan Kaskey is joined by Timothy Smith, Senior Director of AI Innovation and Head of the Data Sciences Communities at Takeda, to explore how AI is transforming drug discovery...
Lessons on Leading Through Uncertainty in Pharma
In this episode of Pharma Sessions, host Jonathan Kaskey welcomes back Danie du Plessis, the first-ever guest on Pharma Sessions, for a wide-ranging conversation about what it takes to lead in medical affairs today....
Where AI Delivers Real Value in Pharma Today with Emily Lewis
Here’s what keeps pharma leaders awake at night: 70% to 80% of ChatGPT usage is healthcare-related; however, most pharmaceutical organizations still treat AI as a future consideration rather than an immediate...
